Fda Approval Of Remdesivir - A Step In The Right Direction
NEW ENGLAND JOURNAL OF MEDICINE（2020）
Abstract
On October 22, 2020, on the basis of the results of three phase 3 clinical trials, the FDA approved remdesivir for use in adults and pediatric patients (12 years of age or older and weighing at least 40 kg) for the treatment of Covid-19 requiring hospitalization.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined